Samar Al Bitar

450 total citations
9 papers, 315 citations indexed

About

Samar Al Bitar is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Samar Al Bitar has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Surgery. Recurrent topics in Samar Al Bitar's work include Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Samar Al Bitar is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Epigenetics and DNA Methylation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Samar Al Bitar collaborates with scholars based in Lebanon, United States and Germany. Samar Al Bitar's co-authors include Hala Gali‐Muhtasib, Wassim Abou‐Kheir, Samer Doughan, Marwan El‐Sabban, Alissar Monzer, Hisham F. Bahmad, Ola Hadadeh, Mohamed Jamal, Mohamed Al‐Sayegh and Matthias Ocker and has published in prestigious journals such as International Journal of Molecular Sciences, Behavioural Brain Research and World Journal of Gastroenterology.

In The Last Decade

Samar Al Bitar

9 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Al Bitar Lebanon 5 170 101 58 33 28 9 315
Fei Xie China 12 159 0.9× 98 1.0× 67 1.2× 29 0.9× 18 0.6× 35 346
Chan Woo Kang South Korea 8 172 1.0× 88 0.9× 95 1.6× 55 1.7× 27 1.0× 17 368
Yuqing Wen China 13 167 1.0× 84 0.8× 95 1.6× 59 1.8× 53 1.9× 27 348
Lixia Wang China 8 232 1.4× 112 1.1× 55 0.9× 59 1.8× 44 1.6× 11 388
Tonggang Qi China 13 188 1.1× 58 0.6× 80 1.4× 46 1.4× 21 0.8× 21 347
Song‐Bin Guo China 11 167 1.0× 77 0.8× 71 1.2× 38 1.2× 42 1.5× 23 354
Sung Lyea Park South Korea 12 176 1.0× 50 0.5× 73 1.3× 27 0.8× 37 1.3× 20 351
Zhengchen Jiang China 9 135 0.8× 63 0.6× 49 0.8× 43 1.3× 41 1.5× 30 318
Shuya Sun China 11 192 1.1× 68 0.7× 65 1.1× 24 0.7× 19 0.7× 20 324
Lang He China 13 211 1.2× 62 0.6× 81 1.4× 61 1.8× 37 1.3× 31 354

Countries citing papers authored by Samar Al Bitar

Since Specialization
Citations

This map shows the geographic impact of Samar Al Bitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Al Bitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Al Bitar more than expected).

Fields of papers citing papers by Samar Al Bitar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Al Bitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Al Bitar. The network helps show where Samar Al Bitar may publish in the future.

Co-authorship network of co-authors of Samar Al Bitar

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Al Bitar. A scholar is included among the top collaborators of Samar Al Bitar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Al Bitar. Samar Al Bitar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Monzer, Alissar, Farah Ballout, Samar Al Bitar, et al.. (2024). ONC206, an imipridone derivative, demonstrates anti-colorectal cancer activity against stem/progenitor cells in 3D cell cultures and in patient-derived organoids. Pharmacological Reports. 77(1). 229–246. 3 indexed citations
2.
Bitar, Samar Al, Marwan El‐Sabban, Samer Doughan, & Wassim Abou‐Kheir. (2023). Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond. World Journal of Gastroenterology. 29(9). 1395–1426. 42 indexed citations
3.
Monzer, Alissar, Farah Ballout, Samar Al Bitar, et al.. (2022). Novel therapeutic diiminoquinone exhibits anticancer effects on human colorectal cancer cells in two-dimensional and three-dimensional in vitro models. World Journal of Gastroenterology. 28(33). 4787–4811. 4 indexed citations
4.
Bitar, Samar Al, Farah Ballout, Alissar Monzer, et al.. (2022). Thymoquinone Radiosensitizes Human Colorectal Cancer Cells in 2D and 3D Culture Models. Cancers. 14(6). 1363–1363. 22 indexed citations
5.
Bitar, Samar Al, Tala Ballouz, Samer Doughan, Hala Gali‐Muhtasib, & Nesrine Rizk. (2021). Potential role of micro ribonucleic acids in screening for anal cancer in human papilloma virus and human immunodeficiency virus related malignancies. World Journal of Gastrointestinal Pathophysiology. 12(4). 59–83. 4 indexed citations
6.
Bahmad, Hisham F., Darine Daher, Ola Hadadeh, et al.. (2021). The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update. International Journal of Molecular Sciences. 22(14). 7667–7667. 55 indexed citations
7.
Bitar, Samar Al, et al.. (2019). Sleep restriction alters the temporal expression of major histocompatibility complex class II molecules in murine lymphoid tissues. Behavioural Brain Research. 362. 152–159. 3 indexed citations
8.
Ocker, Matthias, Samar Al Bitar, Ana Carolina Monteiro, Hala Gali‐Muhtasib, & Regine Schneider‐Stock. (2019). Epigenetic Regulation of p21cip1/waf1 in Human Cancer. Cancers. 11(9). 1343–1343. 30 indexed citations
9.
Bitar, Samar Al & Hala Gali‐Muhtasib. (2019). The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics. Cancers. 11(10). 1475–1475. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026